The path to a better biomarker: Application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice
International Immuno-Oncology Biomarker Working Group
Research output: Contribution to journal › Review article (Academic Journal) › peer-review
158Citations
(Scopus)
Fingerprint
Dive into the research topics of 'The path to a better biomarker: Application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice'. Together they form a unique fingerprint.